Aptevo Therapeutics Inc. (APVO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aptevo Therapeutics Inc.

    NASDAQ: APVO · Real-Time Price · USD
    1.43
    -0.02 (-1.38%)
    At close: Oct 03, 2025, 3:59 PM
    1.44
    0.69%
    After-hours: Oct 03, 2025, 07:48 PM EDT

    Aptevo Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 8.71M 16.9M 22.64M 45.04M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a -6.76M 68K
    Receivables
    		 n/a n/a 2.5M 3.66M
    Inventory
    		 n/a n/a 1.57M 3.08M
    Other Current Assets
    		 256K 689K 744K 2.04M
    Total Current Assets
    		 10.66M 19.07M 27.45M 52.57M
    Property-Plant & Equipment
    		 4.93M 5.78M 6.76M 3.96M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 4.93M 5.78M 6.76M 4.03M
    Total Assets
    		 15.59M 24.84M 34.22M 56.6M
    Account Payables
    		 3.05M 3.98M 3.5M 3.46M
    Deferred Revenue
    		 n/a n/a -3.5M -3.46M
    Short-Term Debt
    		 n/a n/a 2M 11.67M
    Other Current Liabilities
    		 3.15M 1.14M 1.1M 17.55M
    Total Current Liabilities
    		 6.21M 7.22M 8.71M 34.76M
    Long-Term Debt
    		 n/a n/a 1.46M 3.71M
    Other Long-Term Liabilities
    		 n/a n/a n/a 15.58M
    Total Long-Term Liabilities
    		 4.63M 5.4M 7.54M 20.63M
    Total Liabilities
    		 10.84M 12.62M 16.24M 55.38M
    Total Debt
    		 4.63M 5.4M 9.54M 16.71M
    Book Value
    		 4.75M 12.22M 17.97M 1.22M
    Book Value Per Share
    		 344.42 32.52K 114.74K 8.45K
    Common Stock
    		 84K 61K 48K 47K
    Retained Earnings
    		 -247.58M -223.45M -206.04M -214.06M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 4.75M 12.22M 17.97M 1.22M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist